https://biotechmorning.com/news/asco-2026-china-biotech-coming-of-age Biotech Morning en 2026-06-04T14:17:28.282Z The Conference Where China Stopped Following and Started Leading https://biotechmorning.com/news/regeneron-doubles-cytomx-probody-bet Biotech Morning en 2026-06-04T14:16:57.147Z Regeneron Just Doubled a $2B Bet Most of Biotech Had Written Off https://biotechmorning.com/news/alnylam-inceptive-ai-rnai-deal Biotech Morning en 2026-06-04T14:16:01.080Z The RNAi King Just Admitted It Needs an AI Co-Pilot https://biotechmorning.com/news/autoimmune-car-t-durability-cabaletta-bio Biotech Morning en 2026-06-04T14:15:06.539Z The Autoimmune CAR-T Race Has a New Mantra: Make It Last https://biotechmorning.com/news/innovent-cldn18-2-adc-phase-3-win-takeda Biotech Morning en 2026-06-04T14:14:13.791Z Innovent's $1.2B Bet Just Got a Whole Lot More Interesting https://biotechmorning.com/news/germany-loses-pharma-investment-healthcare-reform Biotech Morning en 2026-06-04T14:13:17.645Z Germany Just Lost $2 Billion in Pharma Investment. It Asked For It. https://biotechmorning.com/news/odyssey-therapeutics-304m-ipo-tpg-placement Biotech Morning en 2026-06-03T14:21:59.643Z Odyssey Just Raised $304M Before Most Biotechs Finish Their Slide Decks https://biotechmorning.com/news/travere-billion-dollar-btk-inhibitor-deal Biotech Morning en 2026-06-03T14:21:08.956Z Travere's $1.1B Bet on a Drug It Didn't Build https://biotechmorning.com/news/bms-bispecific-adc-asco-trop2-threat Biotech Morning en 2026-06-03T14:20:15.237Z BMS Just Showed Up to the ADC Party With a Weapon Nobody Expected https://biotechmorning.com/news/lilly-ascidian-rna-exon-editing-kidney-disease-deal Biotech Morning en 2026-06-03T14:19:24.034Z Lilly Just Bet $1.9B on an Editing Trick That Doesn't Touch DNA https://biotechmorning.com/news/celcuity-10-billion-vision-one-drug Biotech Morning en 2026-06-03T14:18:25.360Z Celcuity Wants to Be a $10 Billion Company. It Has One Drug. https://biotechmorning.com/news/cytokinetics-acacia-hcm-non-obstructive-readout Biotech Morning en 2026-06-03T14:17:31.985Z Cytokinetics Waited 27 Years for Its First Drug. Now It Wants to Double Down. https://biotechmorning.com/news/newlimit-435m-cellular-rejuvenation-funding Biotech Morning en 2026-06-03T14:16:41.375Z The Coinbase Guy Wants to Make Your Liver 20 Years Younger https://biotechmorning.com/news/roche-giredestrant-first-line-breast-cancer-miss Biotech Morning en 2026-06-03T14:15:51.270Z Roche's Big Bet on Replacing a Cancer Drug Staple Just Hit a Wall https://biotechmorning.com/news/intellia-crispr-phase-3-hae-results Biotech Morning en 2026-06-03T14:14:55.447Z One Shot to Silence a Gene Forever https://biotechmorning.com/news/legend-biotech-in-vivo-car-t-data Biotech Morning en 2026-06-03T14:14:00.460Z Legend Biotech Just Skipped the Factory. The Results Are Wild.